The area under curve results obtained by ROC curve analysis (1 year: 0.637, 3 years: 0.688, and 5 years: 0.714, Figure 3d) further indicated that measuring the expression of STAT3 is an effective way to evaluate the prognosis of patients with glioma. Here, STAT3 is linked to glioma.